Przejdź do komentarzy
Przejdź do komentarzy

Regulatory management option analysis

The regulatory management option analysis (RMOA) list includes substances for which an RMOA either is under development or has been completed since the start of the implementation of the SVHC Roadmap in February 2013.

For each substance, the table shows the assessing Member State (submitter), the concern, the outcome and the suggested follow-up from the RMOA, and the date of the latest update to the list entry.

Other process details and relevant documents are also available and can be accessed through the ‘Details’ icon for the list entry.

 

Disclaimer to the RMOA list

The responsibility for the content of an RMOA rests with the authority that developed it. It is possible that other authorities do not have the same view, and even develop a further RMOA. Any authority can consequently initiate a regulatory process but should indicate this by appropriate means, such as the Registry of Intentions.

RMOAs and their conclusions are compiled based on available information and may change in light of new information or further assessment.

Last updated 26 listopada 2020. Database contains 260 unique substances/entries.
Filter the list
Date of intention:
Date of RMOA conclusion:
Latest update:

 
231-589-4
7646-79-9
ECHA
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
Restriction
24/10/2018
Details
231-512-4
7601-90-3
Germany
Endocrine disruption
Under development
Under development
No suggestion yet
13/06/2016
Details
231-158-0
7440-48-4
Netherlands
Carcinogenic
Mutagenic
Toxic for reproduction
Under development
On hold
No suggestion yet
09/11/2017
Details
231-150-7
7440-41-7
Germany
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
Other
19/12/2016
Details
231-106-7
7439-97-6
Sweden
Other human toxicity
STOT RE
Toxic for reproduction
Concluded
No need to initiate further regulatory risk management action at this time
None
23/09/2014
Details
231-106-7
7439-97-6
Denmark
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
Other
15/10/2018
Details
231-100-4
7439-92-1
Sweden
Other environmental toxicity
Other human toxicity
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
SVHC
13/10/2017
Details
230-528-9
7173-62-8
Sweden
STOT RE
Concluded
No need to initiate further regulatory risk management action at this time
None
26/04/2019
Details
229-176-9
6422-86-2
France
Carcinogenic
Endocrine disruption
Mutagenic
Toxic for reproduction
Concluded
No need to initiate further regulatory risk management action at this time
None
25/01/2019
Details
227-534-9
5873-54-1
Germany
Respiratory sensitiser
Skin sensitiser
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
Restriction
23/09/2014
Details
227-534-9
5873-54-1
Denmark
Respiratory sensitiser
Skin sensitiser
Toxic for reproduction
Concluded
No need to initiate further regulatory risk management action at this time
None
10/10/2019
Details
226-378-9
5384-21-4
France
Endocrine disruption
Persistence
Toxic for reproduction
Widespread use
Under development
Under development
No suggestion yet
11/03/2016
Details
225-863-2
5124-30-1
Germany
Respiratory sensitiser
Skin sensitiser
Concluded
Appropriate to initiate regulatory risk management action
Restriction
23/09/2014
Details
225-768-6
5064-31-3
Denmark
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
No need to initiate further regulatory risk management action at this time
None
23/09/2014
Details
225-625-8
4979-32-2
Germany
Bioaccumulation
Exposure
Persistence
Widespread use
Under development
Under development
No suggestion yet
28/02/2019
Details
223-861-6
4098-71-9
Sweden
Exposure
Mutagenic
Skin sensitiser
Concluded
No need to initiate further regulatory risk management action at this time
None
09/02/2018
Details
223-861-6
4098-71-9
Germany
Carcinogenic
Exposure
Mutagenic
Other human toxicity
Concluded
Appropriate to initiate regulatory risk management action
Restriction
10/10/2019
Details
223-445-4
3896-11-5
Germany
Carcinogenic
Mutagenic
Toxic for reproduction
Under development
Under development
No suggestion yet
05/12/2014
Details
223-383-8
3864-99-1
Germany
Bioaccumulation
Carcinogenic
Mutagenic
Persistence
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
SVHC
10/07/2015
Details
222-871-8
3644-11-9
Sweden
Carcinogenic
Mutagenic
Under development
Under development
No suggestion yet
08/04/2020
Details
222-583-2
3542-36-7
Netherlands
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
No need to initiate further regulatory risk management action at this time
None
10/10/2019
Details
221-967-7
3296-90-0
Norway
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
SVHC
07/01/2020
Details
221-641-4
3173-72-6
Germany
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
Restriction
10/10/2019
Details
221-573-5
3147-75-9
Germany
Bioaccumulation
Other environmental toxicity
Persistence
Under development
Under development
No suggestion yet
05/12/2014
Details
220-474-4
2778-42-9
Germany
Respiratory sensitiser
Skin sensitiser
Concluded
Appropriate to initiate regulatory risk management action
Restriction
23/09/2014
Details
220-239-6
2682-20-4
Denmark
Skin sensitiser
Concluded
Appropriate to initiate regulatory risk management action
Other legislation
04/05/2015
Details
219-799-4
2536-05-2
Denmark
Carcinogenic
Mutagenic
Respiratory sensitiser
Skin sensitiser
Toxic for reproduction
Concluded
No need to initiate further regulatory risk management action at this time
None
10/10/2019
Details
219-799-4
2536-05-2
Germany
Respiratory sensitiser
Skin sensitiser
Concluded
Appropriate to initiate regulatory risk management action
Restriction
23/09/2014
Details
219-470-5
2440-22-4
Germany
Other human toxicity
Persistence
Toxic for reproduction
Under development
Under development
No suggestion yet
05/12/2014
Details
219-154-7
2374-14-3
Netherlands
Bioaccumulation
Other human toxicity
Persistence
Concluded
Appropriate to initiate regulatory risk management action
CLH
10/07/2015
Details
218-165-4
2058-94-8
Germany
Bioaccumulation
Persistence
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
Restriction
07/03/2017
Details
217-533-1
1879-09-0
France
Carcinogenic
Mutagenic
Skin sensitiser
Toxic for reproduction
Under development
Under development
No suggestion yet
07/03/2017
Details
217-442-7
1852-16-0
Sweden
Carcinogenic
Mutagenic
Under development
Under development
No suggestion yet
08/04/2020
Details
216-036-7
1478-61-1
Sweden
Endocrine disruption
Concluded
Appropriate to initiate regulatory risk management action
CLH
20/12/2018
Details
215-607-8
1333-82-0
Netherlands
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
No need to initiate further regulatory risk management action at this time
None
23/03/2020
Details
215-535-7
1330-20-7
Germany
Carcinogenic
Mutagenic
Respiratory sensitiser
STOT RE
Toxic for reproduction
Under development
Under development
No suggestion yet
24/06/2020
Details
215-271-2
1317-40-4
ECHA
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
No need to initiate further regulatory risk management action at this time
None
08/10/2015
Details
215-204-7
1313-27-5
Denmark
Carcinogenic
Mutagenic
Persistence
Toxic for reproduction
Under development
Under development
No suggestion yet
19/12/2016
Details
215-185-5
1310-73-2
Sweden
Other human toxicity
Concluded
No need to initiate further regulatory risk management action at this time
Other
08/04/2015
Details
215-181-3
1310-58-3
Sweden
Other human toxicity
Concluded
No need to initiate further regulatory risk management action at this time
Other
08/04/2015
Details
215-157-2
1308-06-1
Netherlands
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
SVHC
09/06/2017
Details
215-133-1
1304-56-9
Netherlands
Carcinogenic
Under development
Under development
No suggestion yet
09/11/2017
Details
214-946-9
1222-05-5
France
Endocrine disruption
Concluded
Appropriate to initiate regulatory risk management action
Other
28/01/2020
Details
214-317-9
1120-71-4
ECHA
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
SVHC
06/02/2015
Details
214-012-0
1072-63-5
Sweden
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
SVHC
07/01/2020
Details
213-934-0
1067-53-4
ECHA
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
CLH
13/06/2016
Details
213-103-2
924-42-5
Sweden
Carcinogenic
Mutagenic
Under development
Under development
No suggestion yet
01/09/2020
Details
212-828-1
872-50-4
Commission
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
Restriction
25/10/2018
Details
212-485-8
822-06-0
Germany
Endocrine disruption
Skin sensitiser
Concluded
Appropriate to initiate regulatory risk management action
Restriction
23/09/2014
Details
212-039-2
753-73-1
Netherlands
Other human toxicity
Concluded
Appropriate to initiate regulatory risk management action
Other legislation
10/07/2015
Details

Export search results to:

Categories Display


Route: .live2